...
首页> 外文期刊>Journal of Medicinal Chemistry >Design, Synthesis, and Structural Characterization of Lysine Covalent BH3 Peptides Targeting Mcl-1
【24h】

Design, Synthesis, and Structural Characterization of Lysine Covalent BH3 Peptides Targeting Mcl-1

机译:靶向MCL-1的赖氨酸共价BH3肽的设计,合成和结构表征

获取原文
获取原文并翻译 | 示例
           

摘要

Modulating disease-relevant protein-protein interactions (PPIs) using pharmacological tools is a critical step toward the design of novel therapeutic strategies. Over the years, however, targeting PPIs has proven a very challenging task owing to the large interfacial areas. Our recent efforts identified possible novel routes for the design of potent and selective inhibitors of PPIs using a structure-based design of covalent inhibitors targeting Lys residues. In this present study, we report on the design, synthesis, and characterizations of the first Lys-covalent BH3 peptide that has a remarkable affinity and selectivity for hMcl-1 over the closely related hBfl-1 protein. Our structural studies, aided by X-ray crystallography, provide atomic-level details of the inhibitor interactions that can be used to further translate these discoveries into novel generation, Lys-covalent pro-apoptotic agents.
机译:使用药理学工具调节疾病相关蛋白质相互作用(PPI)是设计新治疗策略的关键一步。然而,多年来,由于界面面积大,以PPI为目标已被证明是一项非常具有挑战性的任务。我们最近的研究发现,利用以赖氨酸残基为靶点的共价抑制剂的基于结构的设计,可能有新的途径来设计有效和选择性的PPI抑制剂。在本研究中,我们报告了第一个Lys共价BH3肽的设计、合成和表征,该肽对hMcl-1具有显著的亲和力和选择性,而不是密切相关的hBfl-1蛋白。我们的结构研究在X射线晶体学的帮助下,提供了抑制剂相互作用的原子级细节,可用于进一步将这些发现转化为新一代Lys共价促凋亡剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号